Remove Communication Remove Events Remove Generic Medicine
article thumbnail

Medicine and medical device shortages: what’s been done and what’s to do

Hospital Pharmacy Europe

In 2022, the Executive Steering Group on Shortages and Safety of Medicinal Products was established to ensure a robust response to medicine supply issues caused by major events or public health emergencies. The paper calls for a European-wide investigation to define the causes and improve communication between stakeholders.

article thumbnail

What a mild recession could mean for small biotechs in 2023

Pharmaceutical Technology

While the ripple effect of such an event is expected across sectors, in the pharmaceutical arena, small and mid-sized enterprises (SMEs) are predicted to be heavily impacted as the economic downturn affects plans to raise capital, amongst other things. million as part of the Build Back Better Regional Challenge.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Cyclobenzaprine interactions to avoid

The Checkup by Singlecare

It’s usually dispensed in pharmacies as a generic medicine, but healthcare providers commonly refer to it by brand names Flexeril (immediate-release tablets), Fexmid (immediate-release tablets), or Amrix (extended-release capsules). Cyclobenzaprine is a prescription muscle relaxant that is approved by the U.S. as a brand-name drug.

article thumbnail

Navigating tariffs and diplomacy: the future of India-US pharmaceutical trade

Pharmaceutical Technology

Amid President Donald Trump’s stated desire to sharply reduce drug prices on the US market, India has also proposed to supply generic medicines at between 20% and 25% of the current reference branded prices, for three years after originator patent expiry. Give your business an edge with our leading industry insights.